Clincosm LogoSign in Get a demo

Stage IV Melanoma

Showing 1 - 25 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participation Patterns Among Stage IV Melanoma Patients

Not yet recruiting
  • Stage IV Melanoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Sep 17, 2022

    Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • Sargramostim (GM-CSF)
    • Pembrolizumab (anti-PD-1)
    • Boston, Massachusetts
    • +1 more
    Jul 6, 2022

    Anxiety, Stage IV Melanoma Trial in Miami Beach (psilocybin)

    Withdrawn
    • Anxiety
    • Stage IV Melanoma
    • Miami Beach, Florida
      Mount Sinai Comprehensive Cancer Center
    Jun 13, 2022

    Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)

    Recruiting
    • Stage III Melanoma
    • Stage IV Melanoma
    • TBX-3400
    • Los Angeles, California
    • +1 more
    May 1, 2022

    Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

    Recruiting
    • Stage IV Melanoma
    • Stage III Melanoma
    • Jette, Brussels, Belgium
      Universitair Ziekenhuis Brussel
    Sep 29, 2021

    Stage IV Melanoma, Advanced Lung Cancer, Stage IV NSCLC Trial in Boston (Educational Video and QPL List, Usual Care)

    Recruiting
    • Stage IV Melanoma
    • +7 more
    • Educational Video and QPL List
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 26, 2021

    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

    Completed
    Has Results
    • Recurrent Melanoma
    • +3 more
    • Washington, District of Columbia
    • +3 more
    May 4, 2021

    Unresectable Stage III Melanoma, Stage IV Melanoma Trial in Worldwide (Nivolumab + Ipilimumab, Encorafenib + Binimetinib)

    Recruiting
    • Unresectable Stage III Melanoma
    • Stage IV Melanoma
    • Nivolumab + Ipilimumab
    • Encorafenib + Binimetinib
    • Antwerpen, Belgium
    • +42 more
    Apr 20, 2021

    Stage IV NSCLC, Stage IV Melanoma, Triple Negative Breast Cancer Trial in Ramat Gan (ImmunicomAIAC)

    Recruiting
    • Stage IV Non-small Cell Lung Cancer
    • +3 more
    • ImmunicomAIAC
    • Ramat Gan, Israel
      Sheba Medical Center
    Mar 22, 2021

    Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

    Completed
    Has Results
    • Adult Solid Tumor
    • +38 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Feb 18, 2021

    Stage IV Melanoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

    Terminated
    Has Results
    • Stage IV Melanoma
    • Antineoplaston therapy (Atengenal + Astugenal)
    • Houston, Texas
      Burzynski Clinic
    Dec 16, 2020

    Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor

    Completed
    Has Results
    • Stage III Melanoma
    • +3 more
    • BRAF inhibitor dabrafenib and MEK inhibitor trametinib
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center, University of North Caro
    Nov 3, 2020

    Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, other, procedure)

    Completed
    Has Results
    • Recurrent Melanoma
    • Stage IV Melanoma
    • Rochester, Minnesota
      Mayo Clinic
    Sep 28, 2020

    Recurrent Melanoma, Stage IV Melanoma Trial in Los Angeles (Raf kinase inhibitor LGX818, binimetinib, laboratory biomarker

    Withdrawn
    • Recurrent Melanoma
    • Stage IV Melanoma
    • Raf kinase inhibitor LGX818
    • +2 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Jul 23, 2020

    Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)

    Completed
    • Stage IV Melanoma
    • recombinant interferon alfa-2b
    • +4 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
    Jul 22, 2020

    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (aldesleukin, ipilimumab, laboratory

    Completed
    • Recurrent Melanoma
    • +4 more
    • aldesleukin
    • +2 more
    • Maywood, Illinois
    • +4 more
    Jun 17, 2020

    Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

    Completed
    • Metastatic Melanoma
    • +2 more
    • Augusta, Georgia
    • +5 more
    Jun 3, 2020

    Stage IV Melanoma, Metastatic Melanoma Trial in United States (HyperAcute®-Melanoma (HAM) Immunotherapy, Ipilimumab,

    Active, not recruiting
    Has Results
    • Stage IV Melanoma
    • Metastatic Melanoma
    • HyperAcute®-Melanoma (HAM) Immunotherapy
    • +3 more
    • Niles, Illinois
    • +4 more
    May 26, 2020

    Recurrent Melanoma, Stage IV Melanoma Trial in Philadelphia (CD40 agonist mAb CP-870,893, tremelimumab, laboratory biomarker

    Completed
    • Recurrent Melanoma
    • Stage IV Melanoma
    • CD40 agonist monoclonal antibody CP-870,893
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Apr 6, 2020

    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)

    Completed
    Has Results
    • Recurrent Melanoma
    • +4 more
    • cytology specimen collection procedure
    • +4 more
    • Scottsdale, Arizona
    • +7 more
    Dec 16, 2019

    Stage IV Melanoma, Stage III Melanoma Trial in Australia (IMP321 (eftilagimod alpha), Pembrolizumab)

    Completed
    • Stage IV Melanoma
    • Stage III Melanoma
    • Brisbane, Queensland, Australia
    • +6 more
    Dec 17, 2019

    Unresectable Stage III, Stage IV Melanoma Trial in Worldwide (Lenvatinib)

    Completed
    Has Results
    • Unresectable Stage III
    • Stage IV Melanoma
    • Birmingham, Alabama
    • +94 more
    Oct 23, 2019

    Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial in Columbus, Philadelphia (Ipilimumab, Whole-Brain

    Completed
    Has Results
    • Recurrent Melanoma
    • +2 more
    • Columbus, Ohio
    • +1 more
    Jul 12, 2019